This study is not accepting new patients

Master Rollover Protocol for Continued Safety Assessment of Study Drug

a study on Cancer, General Neoplasms

Summary

Eligibility
for people ages 18 years and up (full criteria)
Location
at Torrance 5403022, California 5332921 and other locations
Dates
study started
Principal Investigator
by Dr. Parvin Fatheddin Peddi

Description

Summary

This study is for patients who have participated in a previous study and who continue to receive benefit to have continued access to study drug and/or treatment.

Keywords

Cancer, Neoplasms, LY3023414

Eligibility

You can join if…

Open to people ages 18 years and up

  • To be eligible patients must be currently receiving benefit in a concluded Lilly study for a compound that has opened an addendum in the continued access protocol.

You CAN'T join if...

  • Patients must not be concurrently enrolled in any other type of medical research judged not to be scientifically or medically compatible with this study.

Locations

  • UCLA Medical Center not accepting new patients
    Torrance 5403022 California 5332921 90505 United States
  • Sarah Cannon Cancer Center not accepting new patients
    Nashville 4644585 Tennessee 4662168 37203 United States
  • Fort Wayne Oncology & Hematology not accepting new patients
    Fort Wayne 4920423 Indiana 4921868 46804 United States

Lead Scientist at UCLA

Details

Status
not accepting new patients
Start Date
Sponsor
Eli Lilly and Company
ID
NCT02632994
Study Type
Expanded Access
Last Updated